The objective of this study is to evaluate the activity of gelatin hydrogels incorporating combined stromal cell-derived factor-1 (SDF-1) and bone morphogenetic protein-2 (BMP-2) on the in vivo bone regeneration at an ulna critical-sized defect and subcutaneous site of rats, and compared with that of those incorporating either SDF-1 or BMP-2. The similar release profile of SDF-1 and BMP-2 from the hydrogels was observed with or without the combination of BMP-2 and SDF-1, respectively. An enhanced bone regeneration by the hydrogels incorporating combined SDF-1 and BMP-2 was observed. In addition, the implantation of hydrogels incorporating combined SDF-1 and BMP-2 enhanced the expression level of CXC chemokine cell-surface receptor-4 (Cxcr4), Runt-related factor-2 (Runx2), and Osteocalcin genes. The experiments with green fluorescent protein (GFP)positive Chimeric mice revealed that the recruitment of bone marrow-derived cells was promoted and a vascular-like structure together with strong accumulation of CD31-and CD34-positive cells was observed at the site of hydrogels incorporating combined SDF-1 and BMP-2 implanted. In addition, a large fraction of CD29-and CD44-positive nonhematopoietic cells was detected. It is concluded that the combined release of SDF-1 and BMP-2 enhanced the recruitment of osteogenic cells and angiogenesis, resulting in the synergistic effect on bone regeneration.
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Introduction
Tissue engineering is a newly emerging biomedical technology to promote the cell potentials of proliferation and differentiation and has been extensively studied to induce the regeneration and repairing of defective tissues over last 20 years. Many researches have been attempted to design the substitutes of natural microenvironment by providing the components of extracellular matrix (ECM), growth factors, cells, and the combination in different manners [1] . For bone tissue engineering, the combination of these multiple cues is required since the mechanism of bone repairing is complex and regulated by many factors, including the characteristics of ECM scaffolds, the type of angiogenic and osteogenic growth factors, and the osteogenic potential of cells [2] . In addition to tissue engineering-based regeneration therapy, the transplantation of various cells has been performed experimentally and clinically.
However, the cell transplantation does not always obtain the good result of tissue regeneration because of the limitations of cell source, the low survival rate of cells transplanted [3, 4] , and the immunogenic responses of transplanted vs. host cells [5] . Also, the  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   5 phenomenon demonstrates ectopic bone formation due to the accumulation of osteogenic cells.
Angiogenesis is important for the process of bone regeneration and the combination of angiogenic factors further enhanced the bone regeneration induced by osteogenic factors [23, 24] . Based on these findings, we hypothesized that a local release of combined SDF-1 and BMP-2 may facilitate the recruitment of host circulating stem cells to the site implanted, and achieve the consequent angiogenesis and bone regeneration. To this end, the controlled release system to prolong the in vivo half-life of growth factors is required [25] . In this study, gelatin hydrogels were selected as the controlled release carriers since our previous researches confirm that the controlled release of SDF-1 and BMP-2 from gelatin hydrogels successfully induced angiogenesis and bone regeneration, respectively [9, 18] . The potential of combined SDF-1 and BMP-2 release from the gelatin hydrogels to induce bone regeneration has not been investigated yet.
This study is undertaken to evaluate the bone regeneration of gelatin hydrogels incorporating combined SDF-1 and BMP-2, comparing with that of hydrogels incorporating either SDF-1 or BMP-2. Bone regeneration was investigated at an ulna critical-sized defect and ectopically the back subcutis of rats in terms of radiological, micro-computed tomography (µCT), peripheral quantitative computed tomography (pQCT), and histological examinations. In addition, the expression of osteogenic genes of cells in the hydrogels implanted was evaluated to compare it among the different hydrogels incorporating SDF-1, BMP-2, and the combination. We also examined the recruitment of GFP-positive-bone marrow-derived mesenchymal stem cells and endothelial positive cells into the site of hydrogels implanted. In addition, the number of live cells and the fraction type of nonhematopoietic cells in the hydrogels implanted were analyzed by flow cytometry. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   8 Master Mix (Applied Biosystems) and 10 μM of each primer (Table 1) to analyze the expression level of CXC chemokine cell-surface receptor-4 (Cxcr4) and Runt-related factor-2 (Runx2). The reaction mixture was incubated for the initial denaturation at 95 C for 10 min, followed by 40 PCR cycles. Each cycle consisted of the following three steps; 94 C for 15 sec, 57 C for 15 sec and 72 C for 1 min. Each mRNA level was normalized by the expression level of 18S ribosomal RNA as an internal control. The activity of alkaline phosphatase (ALP) for cells cultured similarly was assayed by p-nitrophenyl phosphate method 3 days after culture [26] . Each experiment was independently performed for 3 samples.
Gelatin hydrogels (1 x 6 x 6 mm 3 ) incorporating PBS, 500 ng of SDF-1, 500 ng of SDF-1 and 300 ng of BMP-2, and 300 ng of BMP-2 were prepared by dropping the solution (20 µl) onto the hydrogel freeze-dried, followed by leaving at 4 C overnight to allow the solution incorporation. Next, 50 µl of cell suspension (10 6 cells) was seeded into each hydrogel for 6 hr by the agitation seeding technique reported previously [26] . Then, 1 ml of α-MEM containing 0.5 vol% FBS was added into each cells-seeded hydrogel and the cells were cultured for 3 days without further medium change. The hydrogels were collected, washed with PBS, and the total RNA was extracted by using RNeasy® fibrous tissue mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The RT-PCR assay was performed as described previously to evaluate the expression level of Cxcr4 and Runx2 genes of MSC cultured in the hydrogels.
In vivo release test of SDF-1 and BMP-2 from gelatin hydrogels
SDF-1 and BMP-2 were radioiodinated according to the conventional chloramine T method as previously described [27] . Briefly, 5 μl of Na 125 I was added into 200 μl of SDF-1 or BMP-2 solution (150 μg/ml) in 0.5 M potassium phosphate-buffered solution (pH 7.5) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   9 containing 0.5 M NaCl. Then, 100 μl of the same buffer containing 0.2 mg/ml chloramine-T was added to the solution mixture. After vortex mixing at room temperature for 2 min, 100 μl of PBS containing 0.4 mg sodium metabisulfate was added to the reacting solution to stop the radioiodination. The solution mixture was passed through a PD-10 desalting column (GE Healthcare Life Sciences, Chalfont St Giles, UK) to remove the uncoupled, free 125 I molecules from the 125 I-labeled SDF-1 or 125 I-labeled BMP-2 using PBS as an eluting solution. PBS solution containing 125 I-labeled SDF-1 (4.3 µg/ml) or 125 I-labeled BMP-2 (13.7 µg/ml) was mixed with PBS containing non-labeled SDF-1 or BMP-2 to give the final concentrations of 232 and 202 µg/ml, respectively. The mixed solution containing 5 µg of SDF-1 and/or 3 µg of BMP-2 (20 µl) was then adsorbed onto a freeze-dried gelatin hydrogel
(1 x 6 x 6 mm 3 ), followed by leaving at 4 C overnight to obtain hydrogels incorporating 125 Ilabeled SDF-1 or 125 I-labeled BMP-2. The hydrogel samples used for the in vivo release test are gelatin hydrogels incorporating 5 µg of 125 I-labeled SDF-1, 5 µg of 125 I-labeled SDF-1 and 3 µg of non-labeled BMP-2, 5 µg of non-labeled SDF-1 and 3 µg of 125 I-labeled BMP-2, and 3 µg of 125 I-labeled BMP-2. Following the implantation into the back subcutis of 6-weekold female C57BL/6 mice, the hydrogels were taken out at different time intervals to count the radioactivity remaining by the gamma counter (Auto Well Gamma System ARC-380 CL, Aloka Co., Ltd, Tokyo, Japan). Each experiment was independently performed for 3 samples at each sampling time.
In vivo degradation test of gelatin hydrogels
To evaluate the in vivo degradation profile of gelatin hydrogels, the implantation of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 resulting solution (20 μl) was adsorbed onto a freeze-dried gelatin hydrogel, followed by leaving at 4 C overnight to introduce 125 I into the amino groups of gelatin. The radioiodinated hydrogels were washed with DDW thoroughly to exclude the uncoupled, free 125 I molecules till to make the DDW radioactivity to the background level. Following the implantation into the back subcutis of mice, the hydrogels were taken out at different time intervals to count the radioactivity remaining by the gamma counter. Each experiment was independently performed for 3 samples at each sampling time.
Evaluation of in vivo bone regeneration at ulna critical-sized defect
A bone defect model of rat ulna was prepared to evaluate the bone regeneration of hydrogels incorporating SDF-1 and/or BMP-2. The surgery was made for 12-week-old male Wistar rats (n = 12) under standard sterile conditions according to the procedure previously reported [28] . Briefly, the rats were anesthetized with an intraperitoneal injection of pentobarbital sodium solution (35-40 mg/kg body weight). After shaving the hair and disinfection with 70 vol% ethanol, a longitudinal incision was made along the forearm skin of rats. The periosteum was incised circumferentially to approach to the ulna bone. A critical defect of 6 mm length was then created at the middle position of ulna bone using a sidecutting diamond disk and a high-speed micromotor under an abundant irrigation with sterile saline solution [29] . The hydrogels were implanted into the defects while the periosteum and overlying muscle were repositioned with an absorbable polydioxanone suture (Ethicon 7-0, NJ). Then, the wound was closed with a non-absorbable polypropylene suture (Ethicon 4-0, NJ 
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of SDF-1 and 3 µg of BMP-2, and 3 µg of BMP-2. Each rat received the implantation of 2 hydrogels randomly in both left and right of forearm's ulna. Each experiment was independently performed for 6 samples.
Evaluation of in vivo ectopic bone formation at back subcutis
Ectopic bone formation by gelatin hydrogels incorporating SDF-1 and/or BMP-2 was assessed for 12-week-old male Wistar rats (n = 12) under standard sterile conditions. Briefly, the rats were anesthetized, shaved the hair, and disinfected with 70 vol% ethanol. A vertical incision was created down the midline of the back. The hydrogels (1 x 6 x 6 mm 3 ) were inserted subcutaneously away from the incision. The wound was sutured and disinfected with betadin. The 4 types of hydrogels similar to the bone defect model were randomly implanted.
To evaluate gene expression by the RT-PCR assay, the hydrogels implanted were taken out with a surgical scalpel. The total RNA was extracted by using RNeasy fibrous tissue mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The RT-PCR assay was performed as described previously to evaluate the expression level of Cxcr4 and Runx2 genes of cells in the hydrogels implanted. Expression level of Cxcr4 gene was assessed 3 days after implantation, and that of Runx2 and Osteocalcin genes of osteogenic marker was done 2 and 4 weeks after implantation.
Radiological and histological examinations of bone tissue regenerated
The bone tissue regenerated at the defect and subcutaneous site, 4 weeks later, were radiologically examined by the soft x-ray machine (Hitex-100, Hitachi Ltd., Tokyo, Japan) at 56 kV and 2.5 mA for 20 sec. Then, the samples were fixed with 3 wt% paraformaldehyde in PBS at room temperature for 48 hr, decalcified with PBS containing 9 wt% ethylenediamine tetraaceticacid disodium salt and 10 wt% ethylenediamine tetraaceticacid tetrasodium salt 
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(EDTA) solution at room temperature for 7 days. The EDTA solution was changed every other day. After decalcification, the samples were equilibrated in PBS containing 15 wt% sucrose for 24 hr, and then in PBS containing 30 wt% sucrose for further 24 hr, embedded in Tissue-Tek OCT Compound (Sakura Finetek Inc., Tokyo, Japan), and frozen on liquid nitrogen. For the histological examination, the 6 µm-thick sections were cut at the center of samples, followed by staining with hematoxylin and eosin (H&E) and Masson trichrome to observe the cell infiltration and collagen newly formed. The images were taken under a microscope (AX80 Provis, Olympus Ltd., Tokyo, Japan) and the area percentage of matured collagen to collagen newly formed was measured by Image J software (Version 1.41, Java™, USA) from each image (20X magnification) randomly selected. Each measurement was performed for 6 images. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   13 Analysis of the regional cortical BMD was carried out for each of 3 tomographic slices at a square region of interest (ROI) generated. Technology (MEXT, Japan). Chimeric mice were prepared according to the procedure reported previously [9, 17] . Briefly, 8-to 10-week-old female C57BL/6 mice were irradiated lethally with 10 Gy of gamma-ray. For the total bone marrow transplantation (BMT), 5 x 10 6 of bone marrow cells prepared from 8-to 10-week-old male GFP transgenic mice was intravenously administered to recipient irradiated mice [30] . After the transplantation, the mice were bred for 5 months to complete the replacement of bone marrow-derived cells to GFP-positive cells. The replacement ratio of GFP-positive-bone marrow-derived cells was 98.1 ± 2.8 % when evaluated by the fluorescence-associated cell sorter method (FACS Calibur, BD Bioscience Ltd., Franklin Lakes, NJ).
Micro-computed tomography (µCT) and peripheral quantitative computed tomography (pQCT) scan examinations of bone regenerated

Evaluation of bone marrow-derived cells recruitment to gelatin hydrogels with GFP
Various gelatin hydrogels were subcutaneously implanted into the back of Chimeric mice in the similar procedure mentioned above. The hydrogels including the surrounding tissue were extracted 2 and 4 weeks post-operatively, and the fluorescent images were taken by a digital microscope (AxioCam MRc 5, Carl Zeiss Inc., Jena, Germany). For immunohistochemistry staining, the hydrogel samples were fixed with 3 wt% paraformaldehyde in PBS at 4 C for 24 hr, equilibrated in PBS containing 15 wt% sucrose at 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 samples were embedded and sectioned (8 µm thickness) as described above. To stain osteocalcin-positive cells, the sections were washed with PBS, blocked with a normal goat serum for 1 hr at room temperature before incubation with a rabbit polyclonal anti-mouse osteocalcin antibody (1:250; Takara Bio Inc., Shiga, Japan) for 1 hr at room temperature.
Then, the sections were stained with a Alexa Flour 546-conjugated goat anti-rabbit IgG (8 µg/ml, Invitrogen Corporation, Ltd., CA) for 45 min at room temperature and cell nuclei were finally stained with Hoechst 33258 (Nacalai Tesque Inc., Kyoto, Japan). After washing, the sections were mounted with Vectashield® (Vector Laboratories, Burlingame, CA). The fluorescence images were taken on a fluorescent microscope (Apotome, Imager.Z1, Carl Zeiss, Jena, Germany).
For the immunohistochemical staining with CD31 and CD34 of endothelial marker, the sections were incubated with a fluorescein isothiocyanate (FITC) anti-mouse CD31
(1:100, BioLegend Inc., CA) or a FITC anti-mouse CD34 (1:100, BD Biosciences Pharmingen Inc., CA) for 1 hr at room temperature. After washing, the sections were stained with a Simple Stain Mouse MAX-PO (Histofine®, Nichirei Biosciences Inc., Tokyo, Japan) for 45 min at room temperature. For bright-field microscopy, bound primary antibodies were detected using DAKO EnVision-Horseradish Peroxidase and 3, 3'-diaminobenzidine (DAB) substrate kit (Vector Laboratories, Burlingame, CA), and counter-stained with Hematoxylin to visualize the cell nuclei. Then, the sections were mounted with an aqueous mounting medium (MGK-S, Matsunami Glass Ind. Ltd., Osaka, Japan) and the images were taken on a microscope (AX80 Provis, Olympus Ltd., Tokyo, Japan). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15
Evaluation of the fraction type of non-hematopoietic stem cells in gelatin hydrogels implanted by flow cytometry
The fraction type of non-hematopoietic stem cells in gelatin hydrogels incorporating SDF-1 and/or BMP-2 implanted was analyzed by flow cytometry after staining with 3 monoclonal antibodies including anti-CD29, anti-CD44, and anti-CD45 (BioLegend Inc., CA) [31] . Similarly to the in vivo experiments described above, various gelatin hydrogels were subcutaneously implanted into the back of 6-week-old female C57BL/6 mice. The hydrogels were taken out 4 weeks post-operatively, minced into small pieces, and incubated in collagenase solution (400 units/ml) at 37 C for 40 min for tissue digestion. The tissues remained were separated from cells by using cell strainer (70 µm, BD Falcon TM , BD Biosciences Inc., MA) and the cells were collected by centrifugation at 2,000 rpm, 4 C, and 5 min (Microcentrifuge 5417R, Eppendorf, Hamburg, Germany). Then, the cells were washed with PBS, blocked with 2.4G2 (anti-FcRII/III) antibody on ice for 15 min, and stained with monoclonal antibodies in PBS containing 2 vol% FBS and 0.1 vol% sodium azide on ice for 15 min. Propidium iodide was used to distinguish dead cells from viable cells. The cells immunostained were analyzed on FACSCanto II flow cytometer (BD Biosciences Inc., MA). Analysis was performed by BD FACSDiva software (BD Bioscience Inc., MA) and FLOWJO software (Tree Star, San Carlos, CA). Each analysis was performed for 3 samples.
Statistical analysis
All the results were statistically analyzed by the unpaired student's t test and p < 0.05 was considered to be statistically significant. Data were expressed as the mean ± the standard deviation. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   16 3. Results Figure 3A shows the time profiles of SDF-1 and BMP-2 released from gelatin hydrogels. An initial burst in SDF-1 release was seen for the first day, and 70 and 80 % of radioactivity were released out from the hydrogels incorporating SDF-1 and combined SDF-1 and BMP-2, respectively. Within the first 3 days, the SDF-1 release was significantly accelerated by the combination of BMP-2. However, this effect became less after 7 days of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 17 release test. On the contrary, irrespective of the SDF-1 combination, BMP-2 showed less burst release than SDF-1 and the radioactivity remaining were around 55 and 45 % for the hydrogels incorporating BMP-2 and combined SDF-1 and BMP-2, respectively. At 14 days, about 10-15 % of SDF-1 was remained in the hydrogels, while the percent remaining of BMP-2 was approximately 22 %. After 28 days, the radioactivity of SDF-1 and BMP-2 remained in every hydrogel was around 5-10%. On the other hand, gelatin hydrogels were gradually degraded over 28 days. Figure 3B shows the relationship of remaining radioactivity between SDF-1 or BMP-2 incorporated in gelatin hydrogels and the hydrogels of release carriers. Irrespective of the type of growth factors, a linear relationship of remaining amount between SDF-1 or BMP-2 and the hydrogels was observed. The time profiles of SDF-1 and BMP-2 release were correlated well with the degradation of the hydrogels (R 2  0.93). Figure 4 shows the soft x-ray and histological images of bone regenerated. New bone tissues were regenerated in the defects implanted with the hydrogels incorporating combined SDF-1 and BMP-2 or BMP-2, although the extent of the former was greater than that of the latter. On the contrary, bone regeneration was not observed in the defects implanted with the hydrogels incorporating SDF-1 or PBS. Similarly to soft x-ray images, histological sections showed abundant collagen formation for the hydrogels incorporating SDF-1 and BMP-2 or BMP-2. On the contrary, a slight formation of collagen was observed in the defect implanted with the hydrogels incorporating SDF-1 or PBS. Figure 5C  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   18 shows the pQCT analysis data. A significantly higher BMD was found in the bone regenerated by the hydrogels incorporating combined SDF-1 and BMP-2 than that of the hydrogels incorporating BMP-2. Apparently, the Osteocalcin expression of cells in the hydrogels incorporating combined SDF-1 and BMP-2 implanted was significantly higher than that of every hydrogel group both the 2 (50-fold increase) and 4 weeks (1,000-fold increase) after implantation. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 19 SDF-1 and BMP-2 induced the larger formation of matured bone tissue (stained as dark pink and blue), followed by the BMP-2 group. On the other hand, a low density of collagen was observed in both the hydrogels incorporating SDF-1 and PBS. Figure 7E shows the area percentage of matured collagen to collagen newly formed. The percentage of matured collagen was significantly higher for the hydrogels incorporating SDF-1 and BMP-2 than that of hydrogels incorporating BMP-2. Figure 8E shows the percentage of GFP-positive cells to total cells recruited into the tissue around hydrogels implanted. Only the hydrogels incorporating combined SDF-1 and BMP-2 showed significantly higher percentage of GFP-positive cells to the total cells, when compared with that of the hydrogels incorporating PBS. At 4 weeks, in addition to the GFP-positive cells, osteocalcin-positive cells were also found inside and around the hydrogels incorporating combined SDF-1 and BMP-2 or BMP-2 implanted. A good merge of GFP-and osteocalcin-positive cells localization (yellow) was detected for both the hydrogel groups. However, the higher density of osteocalcin-positive cells was found in the hydrogels incorporating combined SDF-1 and BMP-2 than that of the hydrogels incorporating BMP-2. Figure 9 shows the immunohistochemistry staining images of CD31-and CD34positive cells recruited into the tissue around hydrogels implanted. Around the hydrogels 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   20 incorporating combined SDF-1 and BMP-2 or BMP-2, CD31-and CD34-positive cells were accumulated. In addition, a vascular-like structure was observed for both the hydrogel groups, particularly around the hydrogels. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   21 
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Discussion
Natural bone regeneration is a complex process in which hematopoietic and bone progenitor cells are regulated by a number of environmental stimuli to coordinately function for osteogenesis. In this study, the system of gelatin hydrogels for combined release of SDF-1 and BMP-2 synergistically enhanced bone regeneration. SDF-1 has an inherent ability to enhance the recruitment of hematopoietic cells [14] [15] [16] [17] and BMP-2 has a potential to promote the osteogenic differentiation of bone progenitor cells [20, 21] and to recruit the cells [8, 9] . If the release of two protein factors works well, it is theoretically possible that the recruitment of hematopoietic and bone progenitor cells will be promoted. The former cells will generate new blood vessels while the latter cells will be differentiated by BMP-2 action, resulting an enhanced bone regeneration. The present study experimentally confirmed that the story works well through the combined release of SDF-1 and BMP-2 with the gelatin hydrogels.
Our previous researches have demonstrated that the hydrogels prepared from gelatin with IEP 9.0 could release SDF-1 or BMP-2 in a controlled fashion [9, 18] . Therefore, in this study, the same gelatin hydrogels were selected for the combined release of SDF-1 and BMP-2. The in vivo release test revealed that the initial release of SDF-1 was accelerated by the BMP-2 combination, but the BMP-2 release was not influenced by the SDF-1 combination. This phenomenon is explained by the viewpoint of interaction forces between the molecules to be released and the material of release carrier. The interaction between the BMP-2 and gelatin is stronger than that of SDF-1 and gelatin. The BMP-2 combination would weaken the interaction force of SDF-1. In the other words, the co-presence of BMP-2 in the hydrogels decreases the site of gelatin to interact with SDF-1, resulting in a large amount of initial diffusional SDF-1 release. Several studies have reported on difference in the release behavior between a single and combined molecules [32, 33] . It is found that the release of 22 indomethacin from a heparin-conjugated polymeric micelle was suppressed by the combination of basic fibroblast growth factor (bFGF) whereas the indomethacin combination did not affect the profile of bFGF release [32] . This result was also explained in terms of the interaction force. In addition, after 14 days of implantation, the remaining amount of BMP-2 in the hydrogels was more than that of the SDF-1, implying a more controlled manner of BMP-2 than SDF-1, which corresponded to the results reported previously [9, 18] . When the release profile of SDF-1 or BMP-2 was plotted against that of gelatin hydrogel degradation, a good correlation between the two profiles was observed. It is conceivable that the mechanisms of SDF-1 and BMP-2 release from the gelatin hydrogels were in the diffusion or carrier degradation manners. SDF-1 and BMP-2 would be initially burst released from the hydrogels by the diffusion mechanism. After that, they were released by the degradation of gelatin hydrogels. The carriers with an optimal degradation profile will contribute to the optimal sustained release of growth factors incorporated to achieve growth factor-induced bone regeneration. In addition to the profile of growth factors release, bone tissue formation is also influenced by the degradation profile of carrier itself [34] . Slow-degraded carriers physically hindered the process of bone formation and biochemically impaired the matrix deposition, resulted in minimal bone formation, while the extent of bone formation could be augmented by the carriers with an appropriate degradability [35] . Based on the finding in this study, the gelatin hydrogels with in vivo biodegradation for 4-5 weeks was selected for bone regeneration [9] .
To investigate the biological effects of SDF-1 and BMP-2 for MSC, the gene expression was evaluated. No influence of SDF-1/BMP-2 mixing ratio on the level of Cxcr4 and Runx2 gene expression and the ALP activity was observed (Figure 1 ). Any combination of SDF-1 and BMP-2 or BMP-2 up-regulated both the Cxcr4 and Runx2 expression. This corresponds the finding that BMP-2 played a role in migration (via the activation of Cxcr4   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 23 pathway) and osteogenic differentiation (via the activation of Runx2 pathway) of MSC in vitro [36] . SDF-1 is one ligand of Cxcr4 on the cell surface, so it does not change the level of Cxcr4 expression [37] . Our previous researches reported that a single delivery of 5 µg of SDF-1 and 3 µg of BMP-2 was effective in enhancing in vivo angiogenesis and bone regeneration, respectively [9, 18] . Thus, in our combined SDF-1/BMP-2 system, it is highly possible to consider that the mixing ratio of SDF-1/BMP-2 affects the biological activity.
However, a significant difference among the mixing ratios was not found in this study. Based on the previous findings, the 500/300 mixing ratio of SDF-1/BMP-2 was then selected for the hydrogel incorporation system. For MSC cultured in the hydrogels incorporating combined SDF-1 and BMP-2, the cell response was quite different from that of the factors without the hydrogel incorporating. A significantly high up-regulation of Runx2 gene was observed compared with the hydrogels incorporating BMP-2. It may be explained that the gelatin hydrogels was effective in prolonging the half-life of SDF-1 and BMP-2 and the consequently enhanced their biological activities for cells [38] .
Gelatin hydrogels incorporating combined SDF-1 and BMP-2 revealed a significant great potential to induce bone regeneration at both the bone defect and subcutaneous site. The level of Osteocalcin gene expression of cells in the hydrogels implanted was substantially upregulated (> 1,000-fold) ( Figure 6E ). Osteocalcin-positive cells were accumulated around the hydrogels implanted ( Figure 8C ). In addition, the fraction of non-hematopoietic cells (CD45negative, CD44-positive, and CD29-positive) which may contain mesenchymal stem cells, was apparently detected (Figure 10 ). Taken together, it is likely that the combined release of SDF-1 and BMP-2 enhanced the number of cells recruited and their osteogenic differentiation thereat. Consequently, the biological event would result in enhanced bone regeneration. The molecular mechanism regulating the osteogenic differentiation and bone regeneration by the combined SDF-1 and BMP-2 delivery system is not clear at present. However, there are some 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   24 reasons to support this synergistic phenomenon. The first possible reason is the enhancement of cell recruitment by both the SDF-1 and BMP-2 through SDF-1/CXCR4 or other signals [12] [13] [14] 39] . It is well recognized that SDF-1 plays a critical role in the recruitment of bone marrow-derived cells including hematopoietic and mesenchymal stem cells, together with inflammatory cells to the site of SDF-1 present [10] [11] [12] [13] [14] [15] [16] . The recruited cells would secret a number of cytokines and growth factors which are necessary to proceed the natural process of tissue regeneration and healing [40] . BMP-2 is also reported to have a property to induce the recruitment of many types of cells [39, 41] . It has been demonstrated that BMP-2 released from the gelatin hydrogels could recruit bone marrow-derived cells via the activation of placental growth factor (PlGF) pathway [9] . The enhanced expression of PlGF consequently promoted the recruitment of progenitor cells from the bone marrow [42] [43] [44] . In this study, it is experimentally confirmed on the chemotactic effect of combined SDF-1 and BMP-2 system on the GFP-positive-bone marrow-derived stem cells in the Chimeric mouse model.
In addition, the higher number of live cells and non-hematopoietic stem cells was detected in the hydrogels incorporating combined SDF-1 and BMP-2 implanted, compared with that of other hydrogels (Figures 10B -D) . Taken together, the enhanced recruitment of bone marrow-derived mesenchymal stem cells together with the other types of cells by the combined SDF-1 and BMP-2 system would be one of the key factors contributing to the accelerated bone regeneration.
The second reason would be the enhanced angiogenesis as a result of the enhanced recruitment of hematopoietic stem cells, which may be committed to endothelial cells. It is well known that the local presence of blood vessels is necessary for wound healing and bone regeneration [45] . Many researchers have demonstrated that angiogenesis was enhanced by vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) family, and other growth factors or chemokines [46, 47] , while SDF-1 is reported to be induced by the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 25 angiogenic growth factors [48, 49] . Schantz et al. [50] examined the homing of mesenchymal stem cells by SDF-1 treatment with an infusion pump in vivo. It was shown that the combination of VEGF, SDF-1, and BMP-6 was effective in inducing vascularization in a poly(caprolactone) scaffold. In addition, a recent research has reported on the role of SDF-1 in the modulating inflammation response by the participation of the recruited stem cells, providing a suitable environment for the materials implanted and subsequent guiding an angiogenesis and wound healing [51] . We have demonstrated that the gelatin hydrogels enabled SDF-1 to locally release, resulting in an enhanced vascularization at the site implanted [18] . In this study, an enhanced number of CD31-and CD34-positive cells accumulated around gelatin hydrogels incorporating SDF-1, in remarked contrast to the hydrogels incorporating PBS. The combined SDF-1 and BMP-2 or BMP-2 release strongly increased the accumulation of positive cells. It is reported that BMP-2 also exhibits an angiogenetic nature [52] [53] [54] . Several researches claim that BMP-2 promoted angiogenesis through the stimulation of Smad 1/5, Erk 1/2, and Id expression [55, 56] . The Id family of transcription factors to regulate the neovascularization has been identified as one of the main BMP-2 signaling pathways [57] . In addition, BMP-2 and BMP-4 induced the production of VEGF by different cells, contributing to the angiogenic response [57, 58] . Furthermore, BMP-2 might enhance angiogenesis through the chemotaxis of monocytes, which can secrete cytokines that promote the formation of blood vessels [59] . Considering the angiogenic property of SDF-1 and BMP-2 reported, it may be reasonable to show the highest expression of endothelial markers around the tissue of hydrogels incorporating SDF-1 and BMP-2 implanted because of the combined angiogenic effect of SDF-1 and BMP-2.
Third possible mechanism is the activation of osteogenic differentiation through the co-requirement of the SDF-1 and BMP-2 signaling axis. Zhu et al. [23] have demonstrated that a SDF-1 signaling is required in in vitro osteogenic differentiation induced by BMP -2 for   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   26 C2C12 and ST2 cells. The blocking of SDF-1 signaling before BMP-2 stimulation strongly suppressed the BMP-2-induced osteogenic differentiation. They revealed that the interaction between SDF-1 and BMP-2 signaling was mediated via the intracellular Smads and MAPK activation. In addition, it was shown that C2C12 cells treated with SDF-1 before BMP-2 stimulation significantly enhanced osteocalcin synthesis. Hosogane et al. [24] have also and CD29 non-hematopoietic cells including the fraction of mesenchymal stem cells [31] . It is thus conceivable that the co-requirement of SDF-1 and BMP-2 for osteogenic differentiation may be a significant factor to achieve bone regeneration.
Based on three mechanisms proposed, the synergistic effect of combined SDF-1 and BMP-2 release on the bone regeneration may be explained. This finding provides a novel controlled release system that simultaneously stimulates bone regeneration through the mechanism of cell recruitment, angiogenesis, and osteogenic diffentiation of body-originating cells. However, it should be noted that the extent of bone formation can be optimized and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   27 augmented by modifying the release kinetics of multiple growth factors. For example, if multiple growth factors can release in a controlled and sequential manner, the release technology will be able to imitate the process of natural bone healing.
Conclusions
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